Cyprus Peptides Tirzepatide 20mg

Tirzepatide 40mg

SKU: CYP-6951
Brand:
Brand Cyprus Peptides100 followers
$473.00

In Stock

A synthetic dual-incretin peptide that activates both GIP and GLP-1 receptors, the active ingredient of approved diabetes and weight-management medicines.

  • Kit: 1 vial × 40mg
  • Form: Lyophilized (freeze-dried) powder
  • Class: Dual GIP / GLP-1 receptor agonist
  • Brand: Cyprus Peptides
Bulk pricingMix any Cyprus Peptides products — every kit from this brand counts toward your tier.
  1. 1–4 kits$473.00full price
  2. 5+ kits$449.355% off
  3. 10+ kits$425.7010% off
  4. 20+ kits$416.2412% off
  5. 50+ kits$402.0515% off
  6. 100+ kits$378.4020% off
ß

Minimum order $100.00 across all brands, before the escrow fee.

◆
Escrow-protected purchaseYour payment is held by us — the brand is only paid after you confirm delivery.
↺
Refund if not deliveredOpen a claim from your order page; upheld claims are refunded to your Escrow Wallet.
✓
Sold by Cyprus PeptidesVetted vendor · ships from Cyprus
⚗
Lab testingNo public report for this listing yet. We can request the batch COA before you order. What to test →

For research use only. Not for human consumption. Not medical advice.

Log in to watch this price

What is Tirzepatide?

Tirzepatide is a 39-amino-acid synthetic peptide built on the native GIP backbone and engineered to also activate the GLP-1 receptor, with a fatty-diacid modification that binds albumin and extends its half-life to roughly five days. It is the active ingredient in approved medicines used for type 2 diabetes and chronic weight management.

This listing is Tirzepatide 40mg from Cyprus Peptides (Cyprus), sold on Stairway to Gray with escrow: your payment is held until the order arrives and only then released to the brand.

How it is understood to work

By engaging both incretin receptors, tirzepatide is studied for enhancing glucose-dependent insulin secretion, suppressing glucagon release and slowing gastric emptying, with GIP-receptor activity proposed to add effects on adipose-tissue lipid handling beyond what GLP-1 agonism alone produces.

Research status

Tirzepatide has completed large clinical trials supporting its approval for type 2 diabetes and obesity, and continues to be studied for metabolic dysfunction-associated liver disease, cardiovascular risk and other endpoints, giving it a considerably deeper clinical evidence base than most experimental peptides. Research-grade material sold here is intended for laboratory study rather than the clinical product.

This listing: Cyprus Peptides Tirzepatide

Other strengths
5mg $371.00 · 20mg $363.00 · 60mg $636.00
Also sold by
JP 40mg $132.60 · TFC Peptides 40mg $125.00 · HK Peptide 40mg $220.00 · Uther Peptide 40mg $220.00 · Zhejiang Peptide Co. Tirzepatide $175.00 · Lilipeptide Tirzepatide $47.00

Lab testing

There is no public lab report for this listing yet. We can ask the brand for the batch COA before you order. Many buyers also split an independent HPLC test with others who bought the same batch.

Request the batch COA · How group testing works

Bought through escrow: the brand is only paid after you confirm delivery. If the parcel never arrives, or an independent test shows the wrong compound or a significant under-fill, open a claim before releasing payment.

Specifications

Compound
Tirzepatide
Also known as
LY3298176
Class
Dual GIP / GLP-1 receptor agonist
Form
Lyophilized (freeze-dried) powder
Molecular formula
C225H348N48O68
Molecular weight
~4813.5 g/mol
Per vial
40mg
Brand
Cyprus Peptides · Cyprus

Handling & storage

Supplied as a lyophilized powder; store unopened vials at -20 C protected from light, and after reconstitution with bacteriostatic water keep refrigerated and use within the timeframe set by the study protocol.

Concentration check: adding 2 ml of bacteriostatic water to one 40mg vial gives 20 mg/ml. The Research Lab calculator in your dashboard works this out for any volume.

Questions

Is research-grade tirzepatide the same molecule as the prescription drug?

The active peptide sequence is the same, but the prescription product is manufactured, formulated and quality-tested under pharmaceutical regulatory standards for clinical dosing, while research-grade vials are intended strictly for laboratory use.

How does tirzepatide’s dual mechanism differ from a GLP-1-only agonist?

A GLP-1-only agonist activates just one incretin receptor, while tirzepatide adds GIP-receptor engagement, which researchers study as a source of additional effects on lipid metabolism and insulin sensitivity beyond GLP-1 activity alone.

For laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.

Reviews

There are no reviews yet.

0.00

Average of 0 reviews

0 reviews
0 reviews
0 reviews
0 reviews
0 reviews
Be the first to review “Tirzepatide 40mg”

Your email address will not be published. Required fields are marked *